Literature DB >> 11418686

Diphosphoryl lipid A from Rhodobacter sphaeroides blocks the binding and internalization of lipopolysaccharide in RAW 264.7 cells.

G D Kutuzova1, R M Albrecht, C M Erickson, N Qureshi.   

Abstract

Diphosphoryl lipid A derived from the nontoxic LPS of Rhodobacter sphaeroides (RsDPLA) has been shown to be a powerful LPS antagonist in both human and murine cell lines. In addition, RsDPLA also can protect mice against the lethal effects of toxic LPS. In this study, we complexed both the deep rough LPS from Escherichia coli D31 m4 (ReLPS) and RsDPLA with 5- and 30-nm colloidal gold and compared their binding to the RAW 264.7 cell line by electron microscopy. Both ReLPS and RsDPLA bound to the cells with the following observations. First, binding studies revealed that pretreatment with RsDPLA completely blocked the binding and thus internalization of ReLPS-gold conjugates to these cells at both 37 degrees C and 4 degrees C. Second, ReLPS was internalized via micropinocytosis (noncoated plasma membrane invaginations) involving formation of caveolae-like structures and leading to the formation of micropinocytotic vesicles, macropinocytosis (or phagocytosis), formation of clathrin-coated pits (receptor mediated), and penetration through plasma membrane into cytoplasm. Third, in contrast, RsDPLA was internalized predominantly via macropinocytosis. These studies show for the first time that RsDPLA blocks the binding and thus internalization of LPS as observed by scanning and transmission electron microscopy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418686     DOI: 10.4049/jimmunol.167.1.482

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Proteasome protease mediated regulation of cytokine induction and inflammation.

Authors:  Nilofer Qureshi; David C Morrison; Julia Reis
Journal:  Biochim Biophys Acta       Date:  2012-06-19

Review 2.  The proteasome: a central regulator of inflammation and macrophage function.

Authors:  Nilofer Qureshi; Stefanie N Vogel; Charles Van Way; Christopher J Papasian; Asaf A Qureshi; David C Morrison
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Helminth-derived immunomodulators: can understanding the worm produce the pill?

Authors:  William Harnett; Margaret M Harnett
Journal:  Nat Rev Immunol       Date:  2010-03-12       Impact factor: 53.106

4.  High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.

Authors:  Andréy Mazarati; Mattia Maroso; Valentina Iori; Annamaria Vezzani; Mirjana Carli
Journal:  Exp Neurol       Date:  2011-08-22       Impact factor: 5.330

5.  Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.

Authors:  Mattia Maroso; Silvia Balosso; Teresa Ravizza; Jaron Liu; Eleonora Aronica; Anand M Iyer; Carlo Rossetti; Monica Molteni; Maura Casalgrandi; Angelo A Manfredi; Marco E Bianchi; Annamaria Vezzani
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

6.  Mammalian Lipopolysaccharide Receptors Incorporated into the Retroviral Envelope Augment Virus Transmission.

Authors:  Jessica Wilks; Egil Lien; Amy N Jacobson; Michael A Fischbach; Nilofer Qureshi; Alexander V Chervonsky; Tatyana V Golovkina
Journal:  Cell Host Microbe       Date:  2015-10-14       Impact factor: 21.023

7.  Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.

Authors:  Judith Olejnik; Adriana Forero; Laure R Deflubé; Adam J Hume; Whitney A Manhart; Andrew Nishida; Andrea Marzi; Michael G Katze; Hideki Ebihara; Angela L Rasmussen; Elke Mühlberger
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

8.  The immunoproteasomes regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages.

Authors:  Julia Reis; Ferdaus Hassan; Xiu Qin Guan; Jing Shen; John J Monaco; Christopher J Papasian; Asaf A Qureshi; Charles W Van Way; Stefanie N Vogel; David C Morrison; Nilofer Qureshi
Journal:  Cell Biochem Biophys       Date:  2011-06       Impact factor: 2.194

9.  Reduced frequency of a CD14+ CD16+ monocyte subset with high Toll-like receptor 4 expression in cord blood compared to adult blood contributes to lipopolysaccharide hyporesponsiveness in newborns.

Authors:  Sigifredo Pedraza-Sánchez; Amy G Hise; Lakshmi Ramachandra; Fabian Arechavaleta-Velasco; Christopher L King
Journal:  Clin Vaccine Immunol       Date:  2013-04-17

10.  Inhibition of corneal inflammation by the TLR4 antagonist Eritoran tetrasodium (E5564).

Authors:  Yan Sun; Eric Pearlman
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.